NeuroBo Pharmaceuticals I...
(NRBO)
undefined
undefined%
At close: undefined
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
Cash & Equivalents | 22.43M | 33.36M | 16.39M | 10.09M | 13.91M | 18.95M | 18.47M | 24.03M | 3.62M | 317.00K |
Short-Term Investments | - | - | - | - | - | - | - | - | - | - |
Long-Term Investments | - | - | - | - | - | - | - | - | - | - |
Other Long-Term Assets | 21.00K | - | - | - | - | 728.00K | 8.00K | 8.00K | 847.00K | - |
Receivables | - | - | - | - | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - | - | - | - | - |
Other Current Assets | 77.00K | 168.00K | 197.00K | 594.00K | 210.00K | 963.00K | 536.00K | 713.00K | 23.00K | 13.00K |
Total Current Assets | 22.51M | 33.53M | 16.58M | 10.68M | 14.12M | 18.95M | 19.01M | 24.75M | 3.64M | 330.00K |
Property-Plant & Equipment | 248.00K | 2.00K | 215.00K | 285.00K | 350.00K | 12.00K | - | - | - | - |
Goodwill & Intangibles | - | - | - | - | - | - | - | - | - | - |
Total Long-Term Assets | 269.00K | 2.00K | 215.00K | 285.00K | 350.00K | 740.00K | 8.00K | 8.00K | 857.00K | 18.00K |
Total Assets | 22.78M | 33.53M | 16.80M | 10.97M | 14.47M | 19.69M | 19.02M | 24.75M | 4.50M | 348.00K |
Account Payables | 821.00K | 708.00K | 830.00K | 2.58M | 638.00K | 170.00K | 4.03M | 2.01M | 10.00K | 21.00K |
Deferred Revenue | - | - | - | - | - | -2.48M | - | - | 1.63M | 48.00K |
Short-Term Debt | 134.00K | - | 52.00K | 48.00K | 44.00K | 9.44M | 1.35M | - | 6.42M | 737.00K |
Other Current Liabilities | 5.00M | 11.08M | 1.27M | 1.07M | 1.40M | -9.39M | 1.01M | 2.11M | 2.48M | 121.00K |
Total Current Liabilities | 5.96M | 11.78M | 2.16M | 3.69M | 2.08M | 9.44M | 6.39M | 4.12M | 8.93M | 879.00K |
Long-Term Debt | 136.00K | - | 45.00K | 70.00K | 94.00K | 141.00K | 8.68M | - | - | - |
Other Long-Term Liabilities | - | - | - | - | - | 86.45M | 3.00K | 1K | 7.95M | - |
Total Long-Term Liabilities | 136.00K | 708.00K | 45.00K | 70.00K | 94.00K | 86.59M | 8.69M | 1K | 7.95M | - |
Total Liabilities | 6.10M | 11.78M | 2.20M | 3.77M | 2.18M | 96.03M | 15.08M | 4.12M | 16.88M | 879.00K |
Total Debt | 203.00K | - | 71.00K | 94.00K | 116.00K | 9.44M | 8.68M | - | 6.42M | 737.00K |
Common Stock | 5.00K | 25.00K | 27.00K | 20.00K | 16.00K | 22.00K | 18.00K | 17.00K | 12.00K | 9.00K |
Retained Earnings | -108.27M | -95.80M | -81.83M | -66.54M | -36.87M | -84.11M | -60.47M | -27.06M | -12.39M | -584.00K |
Comprehensive Income | 0.00 | 0.00 | 4.00K | 14.00K | 12.00K | 2.00K | - | -24.75M | -7.96M | - |
Shareholders Equity | 16.68M | 21.75M | 14.60M | 7.20M | 12.29M | -76.34M | 3.94M | 20.63M | -12.38M | -531.00K |
Total Investments | - | - | - | - | - | - | - | - | - | - |